Australia markets closed

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.9000-0.2400 (-5.80%)
At close: 04:00PM EDT
3.9000 0.00 (0.00%)
After hours: 05:58PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts18181819
Avg. Estimate-0.48-0.49-1.9-1.86
Low estimate-0.64-0.66-2.62-2.46
High estimate-0.4-0.43-1.3-0.88
Year ago EPS-0.54-0.46-1.64-1.9
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts16161716
Avg. Estimate1.4M1.16M4.75M3.61M
Low estimateN/AN/A1.92MN/A
High estimate5M5M8.92M20M
Year ago sales5.53M1.94M65.53M4.75M
Sales growth (year/est)-74.70%-40.30%-92.80%-24.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.59-0.57-0.52-0.49
Actual EPS-0.54-0.46-0.45-0.47
Difference0.050.110.070.02
Surprise %8.50%19.30%13.50%4.10%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.48-0.49-1.9-1.86
7 days ago-0.5-0.51-1.96-1.8
30 days ago-0.49-0.5-1.96-1.81
60 days ago-0.5-0.51-1.95-1.79
90 days ago-0.51-0.53-2.03-1.67
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days7773
Up last 30 days8893
Down last 7 daysN/AN/AN/AN/A
Down last 30 days4569
Growth estimatesFATEIndustrySector(s)S&P 500
Current qtr.11.10%N/AN/AN/A
Next qtr.-6.50%N/AN/AN/A
Current year-15.90%N/AN/AN/A
Next year2.10%N/AN/AN/A
Next 5 years (per annum)-37.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A